NCT01066091

Brief Summary

The nature of dietary lipids, age and perivisceral adiposity could alter the postprandial inflammatory response. It is supposed that there is a relationship between the postprandial inflammatory response and the repartition of fat and lean mass, which could partially explain the muscle mass loss with age. The aim of this study is to compare the inflammatory response of a normal meal or high fat meal (from different fatty acids sources) between young lean and young obese and aged lean and aged obese men.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 10, 2010

Completed
19 days until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

March 25, 2015

Status Verified

January 1, 2011

Enrollment Period

9 months

First QC Date

February 9, 2010

Last Update Submit

March 24, 2015

Conditions

Keywords

Inflammatory responseHigh-fat mealcytokinesBody composition

Outcome Measures

Primary Outcomes (1)

  • Inflammatory profile by interleukin-6 (IL6) concentration in plasma.

    six times per day (kinetic: T0 to T480) on three interventional days

Secondary Outcomes (4)

  • Muscular strength, Body composition

    Once at the first and at the last visit

  • Total plasma lipids (total cholesterol, HDL-Cholesterol, LDL-cholesterol, Triglycerides (TG), non-esterified fatty acid, Plasma hormonal profile, Plasma inflammatory profile, Markers of Endothelial function, Plasma lipopolysaccharide concentration.

    Six times per day (kinetic: T0 to T480), on three interventional days

  • Pro-inflammatory cytokines expression in subcutaneous adipose tissue

    Twice per day (before the meal and 6 hours after), on three interventional days

  • Urinary metabolomic profile

    Three times per days (T0,T240,T480), on three interventional days

Study Arms (3)

mashed potatoes

PLACEBO COMPARATOR

Mashed potatoes is composed of potatoes and Skim milk powder.

Other: Mashed potatoes

Mashed potatoes + Oleic Acid

EXPERIMENTAL

The test meal is mashed potatoes with 1g/Kg of weight of lipids with 75% of Oleic Acid

Other: Mashed potatoes + Oleic acid

Mashed potatoes + Palmitic Acid

EXPERIMENTAL

The test meal is mashed potatoes with 1g/Kg of weight of lipids with 39% of saturated fat with 32% of palmitic acid.

Other: mashed potatoes + Palmitic acid

Interventions

Mashed potatoes: Potatoes + Skim milk powder

mashed potatoes

Mashed potatoes with 1g/Kg of weight, of lipids with 75% of Oleic Acid

Mashed potatoes + Oleic Acid

Mashed potatoes with 1g/Kg of weight, of lipids with 32% of palmitic acid

Mashed potatoes + Palmitic Acid

Eligibility Criteria

Age20 Years - 90 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject giving his written informed consent
  • Male from 20 to 35 years old and more than 60
  • Affiliated to the French National Health Insurance
  • Body mass index (BMI) ≤ 25kg/m² and waist circumference ≤94cm ; or BMI ≥ 28kg/m² and waist circumference ≥ 102cm.
  • Complete blood count (CBC)-platelet, normal liver function and normal coagulation.
  • Serology of Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) negative
  • normal Thyroid Stimulating Hormone(TSH)

You may not qualify if:

  • Previous medical and/or surgery judged by the investigator as incompatible with this study
  • Glaucoma
  • C-reactive protein \> 10 mg/l
  • people over 120 kg
  • People with triglyceridemia \> 3 g/L or with familial hypercholesterolemia
  • Fasting glycemia \> 1,26 g/l, abnormal Oral Glucose Tolerance Test
  • Dietary habits judged by the dietitian as incompatible with the study aim
  • Vegetarians
  • Nutritional allergies or xylocaïn allergy
  • People with eating disorders
  • Heavy consumer of alcohol or cigarette
  • Practising intensive physical exercise
  • People with medication that could interfere with the measured parameters: beta-blockers, statins, anticoagulants, antiplatelet agents, corticosteroids for more than 8 days.
  • Depression or psychiatric treatment
  • Being under someone's supervision
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human nutrition laboratory

Clermont-Ferrand, Auvergne, 63000, France

Location

Related Links

MeSH Terms

Conditions

Obesity

Interventions

Oleic AcidPalmitic Acid

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Oleic AcidsFatty Acids, MonounsaturatedFatty Acids, UnsaturatedFatty AcidsLipidsPalmitic Acids

Study Officials

  • Yves Boirie, MD/PhD

    CRNH

    PRINCIPAL INVESTIGATOR
  • Stephane Walrand, PhD

    Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD, Pr Yves Boirie

Study Record Dates

First Submitted

February 9, 2010

First Posted

February 10, 2010

Study Start

March 1, 2010

Primary Completion

December 1, 2010

Study Completion

January 1, 2011

Last Updated

March 25, 2015

Record last verified: 2011-01

Locations